XDH and hyperuricemia: Several XO inhibitors such as allopurinol and febuxostat are existing first-line drugs used to treat hyperuricemia and gout [8,9], yet their side effects (including renal toxicity, hypersensitivity syndrome, vasculitis, and Stevens–Johnson syndrome) greatly limit their long-time application [10,11].